Literature DB >> 22004727

Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.

Jerilyn K Gray1, Andrew M Paluch, William D Stuart, Susan E Waltz.   

Abstract

Previous studies have shown that the Ron receptor is overexpressed in prostate cancer and Ron expression increases with disease severity in humans and the mouse TRAMP model. Here, the causal role of Ron overexpression in the murine prostate was examined in the development and progression of prostate cancer. Transgenic mouse strains were generated which selectively overexpressed Ron in the prostate epithelium and prostate histopathology was evaluated and compared to wild type controls. Ron overexpression led to the development of prostate intraepithelial neoplasia (mPIN) with local invasion and was associated with increases in prostate cell proliferation and decreases in cell death.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004727      PMCID: PMC3225593          DOI: 10.1016/j.canlet.2011.09.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer.

Authors:  Francis M Sirotnak; Yohung She; Fei Lee; Jing Chen; Howard I Scher
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

2.  A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.

Authors:  J Zhang; T Z Thomas; S Kasper; R J Matusik
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

3.  Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses.

Authors:  S E Waltz; L Eaton; K Toney-Earley; K A Hess; B E Peace; J R Ihlendorf; M H Wang; K H Kaestner; S J Degen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.

Authors:  Y Q Chen; Y Q Zhou; D Angeloni; A L Kurtz; X Z Qiang; M H Wang
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

5.  Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.

Authors:  Carlo Vicentini; Claudio Festuccia; Giovanni Luca Gravina; Adriano Angelucci; Angelo Marronaro; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-04       Impact factor: 4.553

6.  The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.

Authors:  Piera Maggiora; Annalisa Lorenzato; Stefano Fracchioli; Barbara Costa; Massimo Castagnaro; Riccardo Arisio; Dionyssios Katsaros; Marco Massobrio; Paolo M Comoglio; Maria Flavia Di Renzo
Journal:  Exp Cell Res       Date:  2003-08-15       Impact factor: 3.905

7.  Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.

Authors:  Da Wang; Qi Shen; Yi-Qing Chen; Ming-Hai Wang
Journal:  Oncogene       Date:  2004-03-04       Impact factor: 9.867

8.  Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.

Authors:  Paula J Kaplan-Lefko; Tsuey-Ming Chen; Michael M Ittmann; Roberto J Barrios; Gustavo E Ayala; Wendy J Huss; Lisette A Maddison; Barbara A Foster; Norman M Greenberg
Journal:  Prostate       Date:  2003-05-15       Impact factor: 4.104

Review 9.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

10.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

Authors:  Katharine Ellwood-Yen; Thomas G Graeber; John Wongvipat; M Luisa Iruela-Arispe; JianFeng Zhang; Robert Matusik; George V Thomas; Charles L Sawyers
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more
  8 in total

1.  Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.

Authors:  Camille Sullivan; Nicholas E Brown; Juozas Vasiliauskas; Peterson Pathrose; Sandra L Starnes; Susan E Waltz
Journal:  Mol Cancer Res       Date:  2020-05-21       Impact factor: 5.852

2.  Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling.

Authors:  Nicholas E Brown; Angelle Jones; Brian G Hunt; Susan E Waltz
Journal:  Prostate       Date:  2022-07-21       Impact factor: 4.012

Review 3.  Ron receptor tyrosine kinase signaling as a therapeutic target.

Authors:  Nancy M Benight; Susan E Waltz
Journal:  Expert Opin Ther Targets       Date:  2012-07-26       Impact factor: 6.902

4.  Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.

Authors:  Nicholas E Brown; Camille Sullivan; Susan E Waltz
Journal:  EMS Cancer Sci J       Date:  2018-07-30

5.  Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model.

Authors:  Juozas Vasiliauskas; Madison A Nashu; Peterson Pathrose; Sandra L Starnes; Susan E Waltz
Journal:  Oncotarget       Date:  2014-07-30

6.  Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer.

Authors:  Izhar Batth; Huiyoung Yun; Suleman Hussain; Peng Meng; Pawel Osmulski; Tim Hui-Ming Huang; Roble Bedolla; Amanda Profit; Robert Reddick; Addanki Kumar
Journal:  Oncotarget       Date:  2016-03-22

7.  Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.

Authors:  Nicholas E Brown; Andrew M Paluch; Madison A Nashu; Kakajan Komurov; Susan E Waltz
Journal:  Neoplasia       Date:  2018-08-15       Impact factor: 5.715

8.  Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer.

Authors:  Izhar Singh Batth; Shih-Bo Huang; Michelle Villarreal; Jingjing Gong; Divya Chakravarthy; Brian Keppler; Sridharan Jayamohan; Pawel Osmulski; Jianping Xie; Paul Rivas; Roble Bedolla; Michael A Liss; I-Tien Yeh; Robert Reddick; Hiroshi Miyamoto; Rita Ghosh; Addanki P Kumar
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.